Optimum duration of regimens for Helicobacter pylori eradication

Y Yuan, AC Ford, KJ Khan, JP Gisbert… - Cochrane Database …, 2013 - cochranelibrary.com
Background The optimal duration for Helicobacter pylori (H. pylori) eradication therapy is
controversial, with recommendations ranging from 7 to 14 days. Several systematic reviews …

Empiric Quadruple vs. Triple Therapy for Primary Treatment ofHelicobacter pyloriInfection: Systematic Review and Meta-Analysis of Efficacy and Tolerability

J Luther, PDR Higgins, PS Schoenfeld… - Official journal of the …, 2010 - journals.lww.com
OBJECTIVES: Recent treatment guidelines recommend two first-line therapies
forHelicobacter pyloriinfection: proton pump inhibitor (PPI), bismuth, tetracycline, and …

Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years

A Kadayifci, H Buyukhatipoglu, MC Savas, I Simsek - Clinical therapeutics, 2006 - Elsevier
BACKGROUND:: There is increasing concern about the efficacy of current regimens for the
eradication of Helicobacter pylori. OBJECTIVES:: This study examined rates of H pylori …

Ингибиторы протонного насоса: их свойства и применение в гастроэнтерологии

ВА Исаков - 2001 - elibrary.ru
В монографии обобщены данные современной литературы и результаты
исследований автора, посвященные ингибиторам протонного насоса. Основное …

Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for Helicobacter pylori first-line treatment

I Puig, M Baylina, J Sanchez-Delgado… - Journal of …, 2016 - academic.oup.com
Background Due to clarithromycin resistance, the current efficacy of Helicobacter pylori first-
line triple therapies including clarithromycin is low. It seems reasonable to explore …

[HTML][HTML] Clarithromycin Versus Metronidazole in First-Line Helicobacter Pylori Triple Eradication Therapy Based on Resistance to Antimicrobial Agents: Meta-Analysis

M Murata, M Sugimoto, H Mizuno, T Kanno… - Journal of Clinical …, 2020 - mdpi.com
Background: International treatment guidelines for Helicobacter pylori infection recommend
a proton pump inhibitor (PPI)/amoxicillin/clarithromycin (CAM) regimen (PAC) or …

A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and …

MJR Janssen, A Van Oijen… - Alimentary …, 2001 - Wiley Online Library
Background: Triple therapies with proton pump inhibitor/ranitidine bismuth citrate (RBC),
clarithromycin (C) and either amoxicillin (A) or a nitroimidazole (I) are widely accepted as …

[HTML][HTML] Approach to Helicobacter pylori infection in geriatric population

S Cizginer, Z Ordulu, A Kadayifci - World journal of gastrointestinal …, 2014 - ncbi.nlm.nih.gov
The prevalence of Helicobacter pylori (H. pylori) infection and its complications increase with
age. The majority of infected individuals remain asymptomatic throughout the life but 10 …

The efficacy of bismuth containing quadruple therapy as a first‐line treatment option for Helicobacter pylori

A Uygun, A Kadayifci, M Safali, S Ilgan… - Journal of digestive …, 2007 - Wiley Online Library
BACKGROUND: Helicobacter pylori eradication rates have tended to decrease recently,
mostly due to increasing antibiotic‐resistance. The present study aimed to compare the …

Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in …

A Uygun, A Kadayifci, Z Yesilova, M Safali, S Ilgan… - Clinical …, 2008 - Elsevier
Background: The eradication rates of Helicobacter pylori with standard treatments are
decreasing worldwide. Objectives: The primary aim of this study was to compare the …